Heron Neutron Medical Corp. (TPE:7799)

Taiwan · Delayed Price · Currency is TWD

413.00

-11.50 (-2.71%)

At close: Jun 24, 2026

-44.71% (1Y)

Market Cap	65.05B -6.5%
Revenue (ttm)	12.96M +5,561.1%
Net Income	-457.60M
EPS	-2.91
Shares Out	157.51M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,457,243
Open	430.00
Previous Close	424.50
Day's Range	408.00 - 453.00
52-Week Range	300.00 - 984.00
Beta	n/a
Analysts	Strong Buy
Price Target	1,203.33 (+191.36%)
Earnings Date	Jul 24, 2026

About Heron Neutron Medical

Heron Neutron Medical Corp. develops, manufactures, and sells medical instruments. It offers accelerator-based boron neutron capture therapy solutions, including neutron source target system, accelerator system, target system, beam shaping assembly, treatment control system, treatment planning system, and patient positioning system; and ACSI cyclotron products. The company was founded in 2017 and is based in Zhubei, Taiwan. [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2017

Employees 104

Stock Exchange Taiwan Stock Exchange

Ticker Symbol 7799

Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for 7799 stock is "Strong Buy." The 12-month stock price target is $1,203, which is an increase of 191.36% from the latest price.

Price Target

$1,203

(191.36% upside)

Analyst Consensus: Strong Buy

Stock Forecasts